Plotinus, Maybe you know an answer to my question
Post# of 148102
Maybe you know an answer to my question? If Leronlimab has been used in the basket trial for Glioblastoma in the past why is the company now doing a mouse trial. It seems to be a step backwards?
Is this because it’s a focused trial for a specific disease?
I’m just trying to understand the rationale. I don’t have a lot of knowledge in how trials are set up etc.
Thanks in advance.